New personalized genetic mouse model of Lesch-Nyhan syndrome for pharmacology and gene therapy

Abstract

In the current study, we present the results of the generation of a genetically modified mouse strain carrying a deletion in the HPRT1 gene. These mice can be effectively used for the preclinical testing of new drugs aimed at the treatment of Lesch-Nyhan syndrom